Benzinga | Nov 3, 2021 09:12AM EDT

United Therapeutics Q3 Adj. EPS $4.16 Beats $3.59 Estimate, Sales $444.70M Beat $421.45M Estimate

United Therapeutics (NASDAQ:UTHR) reported quarterly earnings of $4.16 per share which beat the analyst consensus estimate of $3.59 by 15.88 percent. This is a 7.22 percent increase over earnings of $3.88 per share from the same period last year. The company reported quarterly sales of $444.70 million which beat the analyst consensus estimate of $421.45 million by 5.52 percent. This is a 17.00 percent increase over sales of $380.10 million the same period last year.